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DISCUSSION and CONCLUSIONS
10th International Conference on Cachexia, Sarcopenia & Muscle Wasting Rome, 8-10 December, 2017 Loss of muscle mass and function is a common occurrence in liver transplant Familial Amyloidotic Polyneuropathy (FAP) patients. Sarcopenia is associated with morbidity and mortality before and after liver transplantation. However, the ability of skeletal muscle mass to recover after transplant remains uncertain, and so as the the importance of clinical exercise prescription. Whole-body dual X-ray absorptiometry (DXA) was used to measure body fat and leansoft tissue. From this data, appendicular skeletal muscle mass (kg) was calculated by summing the muscle mass of the four limbs, assuming that all non-fat and non-bone mass is skeletal muscle. Skeletal Muscle Index (SMI) was calculated adjusting appendicular skeletal muscle mass to the squared height. Functional aerobic capacity was assessed using the 6 min walk test (6MWT) and handgrip strength was measured on the dominant hand using a hand dynamometer.
The prevalence of sarcopenia according to SMI values was 45,5% in males and 41,2% in females. According Dunn (2017) 3 diminished SMI is strongly associated with increased hospitalizations and cost of care In addition, 27,3% of males and 17,6% of the females could be classified as having sarcopenia with low mobility (distance < 400m).
Sarcopenia seems to have a high prevalence in liver transplanted patients and could be also prevalent in FAP patients due to essentially previous malnutrition problems associated to this disease. Liver transplant seems to increase its prevalence, probably because of the aggressive medication with impact on muscle metabolism. However the association between sarcopenia in FAP patients with or without liver transplant was not studied yet. Future studies should examine the efficacy of nonpharmacological, multimodal approaches, such as exercise training and a nutritional intervention, that may substantially reduce the functional decline in TX FAP. A fat mass higher than 16% for males and 26% for females was found in 54,5% of males and 52,9% of females. Values for low handgrip strength related with sarcopenia definition were found in 27,3% of males (handgrip<30kg) and in 17,6% of females (handgrip < 20kg). 
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